Forgot to mention that the Assay Feasibility is already completed:Perth, Australia, 8 February 2017:
Australian life sciences company BARD1 LifeSciences Limited (ASX:BD1) (BARD1 LSL or the Company) today announcedsuccessful results from its Assay Feasibility Study. Highlights
· Assay Feasibility Study completed: Study to evaluate the BARD1 LungCancer Test on a commercial instrument platform for research use only wascompleted in December 2016.
· Results comparable to previous POC study: Statistical analysis ofthe data yielded a ROC-AUC = 0.93, which was comparable to the ROC-AUC = 0.96previously reported for the POC Study.
· Final Report confirms feasibility: MSD data confirms BARD1 LungCancer Test can be performed on a commercial-scale MSD instrument platformusing a standardised method.
https://hotcopper.com.au/threads/ann-successful-assay-feasibility-results.3212921/
Performance Shares, page-17
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
58.0¢ |
Change
0.015(2.65%) |
Mkt cap ! $63.96M | |||
| Open | High | Low | Value | Volume |
| 56.5¢ | 58.0¢ | 56.0¢ | $38.51K | 68.38K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2293 | 56.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 58.0¢ | 13111 | 1 |
View Market Depth
| Last trade - 15.48pm 12/07/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |